Janney Montgomery Scott LLC Sells 366 Shares of Doximity, Inc. (NASDAQ:DOCS)

Janney Montgomery Scott LLC lessened its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 1.9% in the third quarter, Holdings Channel.com reports. The institutional investor owned 19,225 shares of the company’s stock after selling 366 shares during the period. Janney Montgomery Scott LLC’s holdings in Doximity were worth $838,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. William Blair Investment Management LLC boosted its holdings in shares of Doximity by 15.8% during the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock worth $179,122,000 after buying an additional 873,682 shares in the last quarter. Clearbridge Investments LLC grew its holdings in Doximity by 7.1% in the second quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock worth $163,709,000 after purchasing an additional 387,200 shares during the period. Swedbank AB bought a new stake in Doximity in the first quarter valued at $91,673,000. Janus Henderson Group PLC raised its holdings in shares of Doximity by 33.5% during the first quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock valued at $66,594,000 after purchasing an additional 621,590 shares during the period. Finally, Capital World Investors grew its stake in shares of Doximity by 250.7% in the 1st quarter. Capital World Investors now owns 1,714,707 shares of the company’s stock valued at $46,143,000 after buying an additional 1,225,707 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Stock Performance

NASDAQ DOCS opened at $49.40 on Friday. The company has a market capitalization of $9.17 billion, a PE ratio of 56.78, a price-to-earnings-growth ratio of 4.51 and a beta of 1.30. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $61.75. The company has a 50-day simple moving average of $43.40 and a 200 day simple moving average of $34.18.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Baird R W upgraded Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. The Goldman Sachs Group started coverage on shares of Doximity in a research note on Friday. They set a “neutral” rating and a $58.00 price target for the company. Wells Fargo & Company upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $19.00 to $41.00 in a report on Friday, November 8th. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a research report on Friday, November 8th. Finally, Barclays boosted their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a report on Monday, November 11th. Eleven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $51.07.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.